TNBC
Overview
IHD is partnering with Healthy Tarrant County Collaboration (HTCC) to lead a project addressing racial disparity and disease aggression in triple negative breast cancer (TNBC) funded by the Texas Higher Education Coordinating Board (THECB).
Objectives
This project has two interconnected objectives focusing on innovative research and community engagement:
- Identify blood-based biomarkers and molecular signatures as key determinants of racial disparity and disease aggression in TNBC.
- Tailor education to the Stop Six community for a better understanding of TNBC, making early screening, treatment and therapeutic care more available.
Impact & Significance
Triple negative breast cancer (TNBC) is an aggressive form of breast cancer that affects African American patients three times more frequently than Caucasian patients. Disparities in providing care, co-morbid medical conditions, and income affect the overall health of African American patients with TNBC. Recent data suggests these disparities may drive poor health outcomes observed in African American patients with TNBC. Identifying a blood-based biomarker that can predict TNBC at a very early stage will be greatly beneficial in making treatment and therapeutic care more available throughout local communities.
Next Steps
The outcomes of this project will be shared with those living in the Stop Six community, with the goal of increasing awareness, providing culturally responsive education, prevention information, and early detection of TNBC at a stage where treatment strategies are available.
This community engagement initiative is rooted in the identified needs and priorities of the Stop Six community. Through comprehensive data collection and analysis, this project will help provide a better understanding of the challenges, interests, and opportunities within the community to develop and tailor impactful TNBC educational workshops that directly address the needs reflective of the community.